Pharmaceutical Contract Manufacturing. Technology Transfer

This section is devoted to the Contract Manufacturing of Pharmaceuticals at the facilities of independent producers, who are fully compliant with technological processes and Quality Control in accordance with client requirements

Types of Contractors

  • Manufacturers, who specialize only in Contract Manufacturing
  • Manufacturers, who produce their own brands along with Contract Manufacturing

Types of Contract Services

  • Full-cycle manufacturing
  • Performing only some of the manufacturing operations (ex. packaging)
research tube

Oasmia Pharmaceutical signs new agreement with Baxter BioPharma Solutions

Oasmia Pharmaceutical AB (Sweden) announced that the company has signed a new five-year contract with Baxter BioPharma Solutions for global commercial manufacturing of Apealea.
Pharma-Manufacturing

Offset contracts became a new tool to support manufacturing localization in Moscow

Pharmaceuticals and medical products are the priority areas for localization of production in the capital of Russia.
pharma-control

Twelve production lines will be constructed in Moscow

The second offset contract for the supply of medicines will be concluded with LLC R-Opra, providing for the reciprocal investment obligations of the supplier-investor.
manufacturing

Singapore company RV Healthcare intends to localize in Uzbekistan

First Deputy Chairman of the State Committee of the Republic of Uzbekistan for Investments, Sunatulla Bekenov, held a meeting with representatives of the Singapore company RV HEALTHCARE PTE. LTD.
scientist

Canon Medical establishes a joint company with ACT Genomics

Canon Medical System Corporation completed the acquisition of the majority shares of ACTmed, a joint venture company established with ACT Genomics, a Taiwanese molecular diagnostic company.
nacimbio

Nacimbio completed Phase I clinical trials of the rotavirus vaccine

Nacimbio has completed the first phase of clinical trials of the rotavirus vaccine. The new drug will be packaged in Russia in 2020 already, while the full production cycle will be launched in 2026.
pharmstandard

Gilead localizes the production of hepatitis C and HIV drugs in Russia

According to the agreement Pharmstandard production facilities will manufacture Sovaldi® for the treatment of chronic hepatitis C and Truvada® for the treatment of HIV.
stem cells

Takara Bio receives a manufacturing license from Swedish Medical Product Agency

Takara Bio announced that the Medical Products Agency granted a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP conditions.
takeda

Takeda launches production of the Ixazomib in Yaroslavl

The global pharmaceutical company Takeda announces the opening of a production site at its plant in Yaroslavl for manufacturing Ixazomib, an innovative drug for patients with multiple myeloma.

Actual

Contact Manufacturing Companies